Atlas Trials

A Study Comparing the Efficacy of Pataday® Once Daily Relief Extra Strength to Flonase® Allergy Relief in Subjects With Allergic Conjunctivitis

Clinical trial NCT05314621 · COMPLETED

Trial details

NCT number
NCT05314621
Sponsor
Andover Research Eye Institute
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Allergic Conjunctivitis
Start date
2021-12-31
Primary completion
2022-07-24
Enrollment
61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.